Anthropic’s $50,000 Claude-credit grant gets called out as useless for rare-disease research
96Stats · x · 2026-07-22
Anthropic’s $50,000 Claude-credit grants draw criticism from a rare-disease researcher
A researcher who works on rare cancers and AI-assisted detection for uncommon spinal diseases argues that Anthropic’s new up to $50,000 in Claude usage credits is not the same as real research funding.
Key points from the reply:
- For rare diseases, data scarcity is the main bottleneck, not model access.
- Claude is described as useful in general, but weak on rare-data analysis because such cases are underrepresented in training data.
- The commenter says they already work with hospitals in China that build specialized LLMs for rare diseases, which may be a better fit.
- They also criticize the U.S. government for proposed NIH budget cuts of roughly 40%, arguing that labs doing biology need real funding, not credits.
The post is essentially a reaction to Anthropic’s AI for Science initiative and its first focused call for rare-disease research.
More from Companies & People
- Law Professor on Legal Engineering Jobs: Stigma Is Real but Builder Skills Open New Doors — jkubicki · 2026-09-11
- AI safety community mocked as 'bridge engineers' who say bridges can never be safe — Dan_Jeffries1 · 2026-09-11
- SoftBank's Masayoshi Son predicts 100 trillion self-replicating AIs: "humans' era as top life form is ending" — Puzzleheaded-King584 · 2026-09-11
- IIT Madras Launches EdTech Tulna Standards for AI-Powered Learning Products — ravi_iitm · 2026-09-11
- Warp's six non-engineering teams all run on Linear and Claude Code — mon__lim · 2026-09-11
- Anthropic Insiders: Not Everyone at the Lab Believes in High p(doom) — anpaure · 2026-09-11